Tags

Type your tag names separated by a space and hit enter

Neuroprotective effects of erythromycin on cerebral ischemia reperfusion-injury and cell viability after oxygen-glucose deprivation in cultured neuronal cells.
Brain Res. 2014 Nov 07; 1588:159-67.BR

Abstract

This study aims to determine if erythromycin has neuroprotective effects against transient ischemia and oxygen-glucose deprivation (OGD) in cultured neuronal cells. Sprague-Dawley rats were subjected to middle cerebral artery occlusion for 90 min, followed by reperfusion. The animals received a subcutaneous single injection of erythromycin lactobionate (EM, 50mg/kg) or vehicle immediately after ischemia. Infarct volume, edema index, and neurological performance were evaluated at 24 and 72 h after reperfusion. Immunohistochemical analyses for oxidative stress (4-HNE, 8-OHdG) and inflammation (Iba-1, TNF-α) were conducted in the cortex at 24h. Primary cortical neuronal cell cultures were prepared from the cerebral cortices of the animals and then subjected to OGD for 3h. Ten or 100 μM EM was added before OGD to determine the effect of EM on cell viability after OGD. EM significantly reduced infarct volume (p<0.01) and edema volume (p<0.05) and improved neurological deficit scores (p<0.05) at 24 and 72 h. EM significantly suppressed the accumulation of 4-HNE (p<0.01) and 8-OHdG (p<0.01) and markedly reduced Iba-1 (p<0.01) and TNF-α expression (p<0.01). Treatment with 100 μM EM in vitro significantly reduced cell death after OGD. EM reduces neuronal damage following cerebral ischemia and OGD and may have antioxidant and anti-inflammatory effects.

Authors+Show Affiliations

Department of Neurological Science, Graduate School of Medicine, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo 113-8603, Japan; Department of Neurology and Stroke Center, Tokyo General Hospital, 3-15-2 Ekoda, Nakano-ku, Tokyo 165-8906, Japan. Electronic address: yasuo.katayama@mt.strins.or.jp.Department of Neurological Science, Graduate School of Medicine, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo 113-8603, Japan.Department of Neurological Science, Graduate School of Medicine, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo 113-8603, Japan.Department of Neurological Science, Graduate School of Medicine, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo 113-8603, Japan.Department of Neurological Science, Graduate School of Medicine, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo 113-8603, Japan.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

25264351

Citation

Katayama, Yasuo, et al. "Neuroprotective Effects of Erythromycin On Cerebral Ischemia Reperfusion-injury and Cell Viability After Oxygen-glucose Deprivation in Cultured Neuronal Cells." Brain Research, vol. 1588, 2014, pp. 159-67.
Katayama Y, Inaba T, Nito C, et al. Neuroprotective effects of erythromycin on cerebral ischemia reperfusion-injury and cell viability after oxygen-glucose deprivation in cultured neuronal cells. Brain Res. 2014;1588:159-67.
Katayama, Y., Inaba, T., Nito, C., Ueda, M., & Katsura, K. (2014). Neuroprotective effects of erythromycin on cerebral ischemia reperfusion-injury and cell viability after oxygen-glucose deprivation in cultured neuronal cells. Brain Research, 1588, 159-67. https://doi.org/10.1016/j.brainres.2014.09.016
Katayama Y, et al. Neuroprotective Effects of Erythromycin On Cerebral Ischemia Reperfusion-injury and Cell Viability After Oxygen-glucose Deprivation in Cultured Neuronal Cells. Brain Res. 2014 Nov 7;1588:159-67. PubMed PMID: 25264351.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Neuroprotective effects of erythromycin on cerebral ischemia reperfusion-injury and cell viability after oxygen-glucose deprivation in cultured neuronal cells. AU - Katayama,Yasuo, AU - Inaba,Toshiki, AU - Nito,Chikako, AU - Ueda,Masayuki, AU - Katsura,Kenichiro, Y1 - 2014/09/28/ PY - 2014/03/12/received PY - 2014/09/04/revised PY - 2014/09/05/accepted PY - 2014/9/30/entrez PY - 2014/9/30/pubmed PY - 2015/8/5/medline KW - Erythromycin KW - Focal ischemia KW - Inflammation KW - Neuroprotection KW - OGD SP - 159 EP - 67 JF - Brain research JO - Brain Res. VL - 1588 N2 - This study aims to determine if erythromycin has neuroprotective effects against transient ischemia and oxygen-glucose deprivation (OGD) in cultured neuronal cells. Sprague-Dawley rats were subjected to middle cerebral artery occlusion for 90 min, followed by reperfusion. The animals received a subcutaneous single injection of erythromycin lactobionate (EM, 50mg/kg) or vehicle immediately after ischemia. Infarct volume, edema index, and neurological performance were evaluated at 24 and 72 h after reperfusion. Immunohistochemical analyses for oxidative stress (4-HNE, 8-OHdG) and inflammation (Iba-1, TNF-α) were conducted in the cortex at 24h. Primary cortical neuronal cell cultures were prepared from the cerebral cortices of the animals and then subjected to OGD for 3h. Ten or 100 μM EM was added before OGD to determine the effect of EM on cell viability after OGD. EM significantly reduced infarct volume (p<0.01) and edema volume (p<0.05) and improved neurological deficit scores (p<0.05) at 24 and 72 h. EM significantly suppressed the accumulation of 4-HNE (p<0.01) and 8-OHdG (p<0.01) and markedly reduced Iba-1 (p<0.01) and TNF-α expression (p<0.01). Treatment with 100 μM EM in vitro significantly reduced cell death after OGD. EM reduces neuronal damage following cerebral ischemia and OGD and may have antioxidant and anti-inflammatory effects. SN - 1872-6240 UR - https://www.unboundmedicine.com/medline/citation/25264351/Neuroprotective_effects_of_erythromycin_on_cerebral_ischemia_reperfusion_injury_and_cell_viability_after_oxygen_glucose_deprivation_in_cultured_neuronal_cells_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0006-8993(14)01225-6 DB - PRIME DP - Unbound Medicine ER -